Rani Therapeutics (RANI) - 2025 Q3 - Quarterly Results

Exhibit 99.1 Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update - Announced up to $1.085 billion collaboration with Chugai Pharmaceutical Co. for multiple high-value therapeutics - - Completed $60.3 million oversubscribed private placement led by Samsara BioCapital with participation from RA Capital Management, Anomaly, Special Situations Funds, and Invus – – Appointed Abraham Bassan and Vasudev Bailey, Ph.D. to the Board of Directors – - Cash runway expected to extend ...